Loading…

Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer

With dichotomous etiology and pathogenesis, intestinal type and diffuse type gastric cancers vary in their clinical and molecular features to the point of representing distinct entities. However, the differences of tumor-infiltrating immune cells within the two types of gastric cancer have not been...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Immunology, Immunotherapy Immunotherapy, 2020-07, Vol.69 (7), p.1327-1336
Main Authors: Li, Ruochen, Zhang, Heng, Cao, Yifan, Liu, Xin, Chen, Yifan, Qi, Yangyang, Wang, Jieti, Yu, Kuan, Lin, Chao, Liu, Hao, He, Hongyong, Li, He, Chen, Lingli, Shen, Zhenbin, Qin, Jing, Zhang, Weijuan, Sun, Yihong, Xu, Jiejie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c431t-2a69089e56aad11a3ac3656db6d92984dad78820daba56718b70cf57a9780c013
cites cdi_FETCH-LOGICAL-c431t-2a69089e56aad11a3ac3656db6d92984dad78820daba56718b70cf57a9780c013
container_end_page 1336
container_issue 7
container_start_page 1327
container_title Cancer Immunology, Immunotherapy
container_volume 69
creator Li, Ruochen
Zhang, Heng
Cao, Yifan
Liu, Xin
Chen, Yifan
Qi, Yangyang
Wang, Jieti
Yu, Kuan
Lin, Chao
Liu, Hao
He, Hongyong
Li, He
Chen, Lingli
Shen, Zhenbin
Qin, Jing
Zhang, Weijuan
Sun, Yihong
Xu, Jiejie
description With dichotomous etiology and pathogenesis, intestinal type and diffuse type gastric cancers vary in their clinical and molecular features to the point of representing distinct entities. However, the differences of tumor-infiltrating immune cells within the two types of gastric cancer have not been well researched. This study was aimed to evaluate the functional impact of Lauren classification on immune contexture in gastric cancer patients. Tumor tissues of gastric cancer patients from Zhongshan Hospital and gastric cancer data from The Cancer Genome Atlas (TCGA) cohort were analyzed. By immunohistochemistry and flow cytometry, we found that intratumoral CD8 + T cells were more abundant but less functional in diffuse type as compared with those in intestinal type tumor tissues. Survival analysis indicated that CD8 + T cells yielded favorable prognosis only in intestinal type patients other than diffuse type cancer patients. Moreover, such diffuse type-associated CD8 + T cell dysfunction was featured by elevated expression of immunosuppressive factors including interleukin-10 (IL-10), transforming growth factor-β1 (TGF-β1) and indoleamine 2,3-dioxygenase 1 (IDO1). In summary, we found that the density, prognostic significance and functional status of intratumoral CD8 + T cells varied with Lauren subtypes in gastric cancer. These results further indicated Lauren classification might be a potential therapeutic marker, and should be considered in therapeutic decisions, especially immunotherapeutic eligibility.
doi_str_mv 10.1007/s00262-020-02550-7
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11027708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2414567825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-2a69089e56aad11a3ac3656db6d92984dad78820daba56718b70cf57a9780c013</originalsourceid><addsrcrecordid>eNp9UU2LFDEQDaK44-gf8CABL4K0VtIfSZ9Exk8Y8LKeQ02SHrP0JGOSXvDkX7fGWdePg4eQqnqvXqryGHss4IUAUC8LgBxkAxLo9D006g5bia6lku7FXbaCtqMiQHfBHpRyRYGEcbzPLlopT4lYse9bXLKP3M5YSpiCxRpS5MH5WCn1hbtQaoi28mNO-5gosfwa58VzjI5PC0HUgTMvFetSeJp4iDVTfEiZyps3-jm_5NbPcyGE77HUTBoWo_X5Ibs34Vz8o5t7zT6_e3u5-dBsP73_uHm9bWzXitpIHEbQo-8HRCcEtmjboR_cbnCjHHXn0CmtJTjcYT8ooXcK7NQrHJUGC6Jds1dn3eOyO3hn_WnE2RxzOGD-ZhIG8zcSwxezT9dGCJBKgSaFZzcKOX1dfKnmEMppK4w-LcXIVgvdaSAD1uzpP9SrtGT6I2J1oqMBteyJJc8sm1Mp2U-30wgwJ4PN2WBDBpufBhtFTU_-3OO25ZejRGjPhEJQ3Pv8--3_yP4Abeiy5Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414567825</pqid></control><display><type>article</type><title>Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer</title><source>PubMed</source><source>Springer Link</source><creator>Li, Ruochen ; Zhang, Heng ; Cao, Yifan ; Liu, Xin ; Chen, Yifan ; Qi, Yangyang ; Wang, Jieti ; Yu, Kuan ; Lin, Chao ; Liu, Hao ; He, Hongyong ; Li, He ; Chen, Lingli ; Shen, Zhenbin ; Qin, Jing ; Zhang, Weijuan ; Sun, Yihong ; Xu, Jiejie</creator><creatorcontrib>Li, Ruochen ; Zhang, Heng ; Cao, Yifan ; Liu, Xin ; Chen, Yifan ; Qi, Yangyang ; Wang, Jieti ; Yu, Kuan ; Lin, Chao ; Liu, Hao ; He, Hongyong ; Li, He ; Chen, Lingli ; Shen, Zhenbin ; Qin, Jing ; Zhang, Weijuan ; Sun, Yihong ; Xu, Jiejie</creatorcontrib><description>With dichotomous etiology and pathogenesis, intestinal type and diffuse type gastric cancers vary in their clinical and molecular features to the point of representing distinct entities. However, the differences of tumor-infiltrating immune cells within the two types of gastric cancer have not been well researched. This study was aimed to evaluate the functional impact of Lauren classification on immune contexture in gastric cancer patients. Tumor tissues of gastric cancer patients from Zhongshan Hospital and gastric cancer data from The Cancer Genome Atlas (TCGA) cohort were analyzed. By immunohistochemistry and flow cytometry, we found that intratumoral CD8 + T cells were more abundant but less functional in diffuse type as compared with those in intestinal type tumor tissues. Survival analysis indicated that CD8 + T cells yielded favorable prognosis only in intestinal type patients other than diffuse type cancer patients. Moreover, such diffuse type-associated CD8 + T cell dysfunction was featured by elevated expression of immunosuppressive factors including interleukin-10 (IL-10), transforming growth factor-β1 (TGF-β1) and indoleamine 2,3-dioxygenase 1 (IDO1). In summary, we found that the density, prognostic significance and functional status of intratumoral CD8 + T cells varied with Lauren subtypes in gastric cancer. These results further indicated Lauren classification might be a potential therapeutic marker, and should be considered in therapeutic decisions, especially immunotherapeutic eligibility.</description><identifier>ISSN: 0340-7004</identifier><identifier>EISSN: 1432-0851</identifier><identifier>DOI: 10.1007/s00262-020-02550-7</identifier><identifier>PMID: 32200421</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adenocarcinoma - classification ; Adenocarcinoma - immunology ; Adenocarcinoma - pathology ; Biomarkers, Tumor - analysis ; Cancer Research ; CD8 antigen ; CD8-Positive T-Lymphocytes - immunology ; Etiology ; Flow cytometry ; Follow-Up Studies ; Gastric cancer ; Genomes ; Humans ; Immunohistochemistry ; Immunology ; Interleukin 10 ; Intestine ; Lymphocytes ; Lymphocytes T ; Medical prognosis ; Medicine ; Medicine &amp; Public Health ; Oncology ; Original ; Original Article ; Patients ; Prognosis ; Stomach Neoplasms - classification ; Stomach Neoplasms - immunology ; Stomach Neoplasms - pathology ; Survival analysis ; Transforming growth factor-b1 ; Tryptophan 2,3-dioxygenase ; Tumor-infiltrating lymphocytes</subject><ispartof>Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1327-1336</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-2a69089e56aad11a3ac3656db6d92984dad78820daba56718b70cf57a9780c013</citedby><cites>FETCH-LOGICAL-c431t-2a69089e56aad11a3ac3656db6d92984dad78820daba56718b70cf57a9780c013</cites><orcidid>0000-0001-7431-9063</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027708/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027708/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32200421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Ruochen</creatorcontrib><creatorcontrib>Zhang, Heng</creatorcontrib><creatorcontrib>Cao, Yifan</creatorcontrib><creatorcontrib>Liu, Xin</creatorcontrib><creatorcontrib>Chen, Yifan</creatorcontrib><creatorcontrib>Qi, Yangyang</creatorcontrib><creatorcontrib>Wang, Jieti</creatorcontrib><creatorcontrib>Yu, Kuan</creatorcontrib><creatorcontrib>Lin, Chao</creatorcontrib><creatorcontrib>Liu, Hao</creatorcontrib><creatorcontrib>He, Hongyong</creatorcontrib><creatorcontrib>Li, He</creatorcontrib><creatorcontrib>Chen, Lingli</creatorcontrib><creatorcontrib>Shen, Zhenbin</creatorcontrib><creatorcontrib>Qin, Jing</creatorcontrib><creatorcontrib>Zhang, Weijuan</creatorcontrib><creatorcontrib>Sun, Yihong</creatorcontrib><creatorcontrib>Xu, Jiejie</creatorcontrib><title>Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer</title><title>Cancer Immunology, Immunotherapy</title><addtitle>Cancer Immunol Immunother</addtitle><addtitle>Cancer Immunol Immunother</addtitle><description>With dichotomous etiology and pathogenesis, intestinal type and diffuse type gastric cancers vary in their clinical and molecular features to the point of representing distinct entities. However, the differences of tumor-infiltrating immune cells within the two types of gastric cancer have not been well researched. This study was aimed to evaluate the functional impact of Lauren classification on immune contexture in gastric cancer patients. Tumor tissues of gastric cancer patients from Zhongshan Hospital and gastric cancer data from The Cancer Genome Atlas (TCGA) cohort were analyzed. By immunohistochemistry and flow cytometry, we found that intratumoral CD8 + T cells were more abundant but less functional in diffuse type as compared with those in intestinal type tumor tissues. Survival analysis indicated that CD8 + T cells yielded favorable prognosis only in intestinal type patients other than diffuse type cancer patients. Moreover, such diffuse type-associated CD8 + T cell dysfunction was featured by elevated expression of immunosuppressive factors including interleukin-10 (IL-10), transforming growth factor-β1 (TGF-β1) and indoleamine 2,3-dioxygenase 1 (IDO1). In summary, we found that the density, prognostic significance and functional status of intratumoral CD8 + T cells varied with Lauren subtypes in gastric cancer. These results further indicated Lauren classification might be a potential therapeutic marker, and should be considered in therapeutic decisions, especially immunotherapeutic eligibility.</description><subject>Adenocarcinoma - classification</subject><subject>Adenocarcinoma - immunology</subject><subject>Adenocarcinoma - pathology</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Cancer Research</subject><subject>CD8 antigen</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Etiology</subject><subject>Flow cytometry</subject><subject>Follow-Up Studies</subject><subject>Gastric cancer</subject><subject>Genomes</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunology</subject><subject>Interleukin 10</subject><subject>Intestine</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Stomach Neoplasms - classification</subject><subject>Stomach Neoplasms - immunology</subject><subject>Stomach Neoplasms - pathology</subject><subject>Survival analysis</subject><subject>Transforming growth factor-b1</subject><subject>Tryptophan 2,3-dioxygenase</subject><subject>Tumor-infiltrating lymphocytes</subject><issn>0340-7004</issn><issn>1432-0851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9UU2LFDEQDaK44-gf8CABL4K0VtIfSZ9Exk8Y8LKeQ02SHrP0JGOSXvDkX7fGWdePg4eQqnqvXqryGHss4IUAUC8LgBxkAxLo9D006g5bia6lku7FXbaCtqMiQHfBHpRyRYGEcbzPLlopT4lYse9bXLKP3M5YSpiCxRpS5MH5WCn1hbtQaoi28mNO-5gosfwa58VzjI5PC0HUgTMvFetSeJp4iDVTfEiZyps3-jm_5NbPcyGE77HUTBoWo_X5Ibs34Vz8o5t7zT6_e3u5-dBsP73_uHm9bWzXitpIHEbQo-8HRCcEtmjboR_cbnCjHHXn0CmtJTjcYT8ooXcK7NQrHJUGC6Jds1dn3eOyO3hn_WnE2RxzOGD-ZhIG8zcSwxezT9dGCJBKgSaFZzcKOX1dfKnmEMppK4w-LcXIVgvdaSAD1uzpP9SrtGT6I2J1oqMBteyJJc8sm1Mp2U-30wgwJ4PN2WBDBpufBhtFTU_-3OO25ZejRGjPhEJQ3Pv8--3_yP4Abeiy5Q</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Li, Ruochen</creator><creator>Zhang, Heng</creator><creator>Cao, Yifan</creator><creator>Liu, Xin</creator><creator>Chen, Yifan</creator><creator>Qi, Yangyang</creator><creator>Wang, Jieti</creator><creator>Yu, Kuan</creator><creator>Lin, Chao</creator><creator>Liu, Hao</creator><creator>He, Hongyong</creator><creator>Li, He</creator><creator>Chen, Lingli</creator><creator>Shen, Zhenbin</creator><creator>Qin, Jing</creator><creator>Zhang, Weijuan</creator><creator>Sun, Yihong</creator><creator>Xu, Jiejie</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7431-9063</orcidid></search><sort><creationdate>20200701</creationdate><title>Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer</title><author>Li, Ruochen ; Zhang, Heng ; Cao, Yifan ; Liu, Xin ; Chen, Yifan ; Qi, Yangyang ; Wang, Jieti ; Yu, Kuan ; Lin, Chao ; Liu, Hao ; He, Hongyong ; Li, He ; Chen, Lingli ; Shen, Zhenbin ; Qin, Jing ; Zhang, Weijuan ; Sun, Yihong ; Xu, Jiejie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-2a69089e56aad11a3ac3656db6d92984dad78820daba56718b70cf57a9780c013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma - classification</topic><topic>Adenocarcinoma - immunology</topic><topic>Adenocarcinoma - pathology</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Cancer Research</topic><topic>CD8 antigen</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Etiology</topic><topic>Flow cytometry</topic><topic>Follow-Up Studies</topic><topic>Gastric cancer</topic><topic>Genomes</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunology</topic><topic>Interleukin 10</topic><topic>Intestine</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Stomach Neoplasms - classification</topic><topic>Stomach Neoplasms - immunology</topic><topic>Stomach Neoplasms - pathology</topic><topic>Survival analysis</topic><topic>Transforming growth factor-b1</topic><topic>Tryptophan 2,3-dioxygenase</topic><topic>Tumor-infiltrating lymphocytes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Ruochen</creatorcontrib><creatorcontrib>Zhang, Heng</creatorcontrib><creatorcontrib>Cao, Yifan</creatorcontrib><creatorcontrib>Liu, Xin</creatorcontrib><creatorcontrib>Chen, Yifan</creatorcontrib><creatorcontrib>Qi, Yangyang</creatorcontrib><creatorcontrib>Wang, Jieti</creatorcontrib><creatorcontrib>Yu, Kuan</creatorcontrib><creatorcontrib>Lin, Chao</creatorcontrib><creatorcontrib>Liu, Hao</creatorcontrib><creatorcontrib>He, Hongyong</creatorcontrib><creatorcontrib>Li, He</creatorcontrib><creatorcontrib>Chen, Lingli</creatorcontrib><creatorcontrib>Shen, Zhenbin</creatorcontrib><creatorcontrib>Qin, Jing</creatorcontrib><creatorcontrib>Zhang, Weijuan</creatorcontrib><creatorcontrib>Sun, Yihong</creatorcontrib><creatorcontrib>Xu, Jiejie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer Immunology, Immunotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Ruochen</au><au>Zhang, Heng</au><au>Cao, Yifan</au><au>Liu, Xin</au><au>Chen, Yifan</au><au>Qi, Yangyang</au><au>Wang, Jieti</au><au>Yu, Kuan</au><au>Lin, Chao</au><au>Liu, Hao</au><au>He, Hongyong</au><au>Li, He</au><au>Chen, Lingli</au><au>Shen, Zhenbin</au><au>Qin, Jing</au><au>Zhang, Weijuan</au><au>Sun, Yihong</au><au>Xu, Jiejie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer</atitle><jtitle>Cancer Immunology, Immunotherapy</jtitle><stitle>Cancer Immunol Immunother</stitle><addtitle>Cancer Immunol Immunother</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>69</volume><issue>7</issue><spage>1327</spage><epage>1336</epage><pages>1327-1336</pages><issn>0340-7004</issn><eissn>1432-0851</eissn><abstract>With dichotomous etiology and pathogenesis, intestinal type and diffuse type gastric cancers vary in their clinical and molecular features to the point of representing distinct entities. However, the differences of tumor-infiltrating immune cells within the two types of gastric cancer have not been well researched. This study was aimed to evaluate the functional impact of Lauren classification on immune contexture in gastric cancer patients. Tumor tissues of gastric cancer patients from Zhongshan Hospital and gastric cancer data from The Cancer Genome Atlas (TCGA) cohort were analyzed. By immunohistochemistry and flow cytometry, we found that intratumoral CD8 + T cells were more abundant but less functional in diffuse type as compared with those in intestinal type tumor tissues. Survival analysis indicated that CD8 + T cells yielded favorable prognosis only in intestinal type patients other than diffuse type cancer patients. Moreover, such diffuse type-associated CD8 + T cell dysfunction was featured by elevated expression of immunosuppressive factors including interleukin-10 (IL-10), transforming growth factor-β1 (TGF-β1) and indoleamine 2,3-dioxygenase 1 (IDO1). In summary, we found that the density, prognostic significance and functional status of intratumoral CD8 + T cells varied with Lauren subtypes in gastric cancer. These results further indicated Lauren classification might be a potential therapeutic marker, and should be considered in therapeutic decisions, especially immunotherapeutic eligibility.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32200421</pmid><doi>10.1007/s00262-020-02550-7</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7431-9063</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0340-7004
ispartof Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1327-1336
issn 0340-7004
1432-0851
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11027708
source PubMed; Springer Link
subjects Adenocarcinoma - classification
Adenocarcinoma - immunology
Adenocarcinoma - pathology
Biomarkers, Tumor - analysis
Cancer Research
CD8 antigen
CD8-Positive T-Lymphocytes - immunology
Etiology
Flow cytometry
Follow-Up Studies
Gastric cancer
Genomes
Humans
Immunohistochemistry
Immunology
Interleukin 10
Intestine
Lymphocytes
Lymphocytes T
Medical prognosis
Medicine
Medicine & Public Health
Oncology
Original
Original Article
Patients
Prognosis
Stomach Neoplasms - classification
Stomach Neoplasms - immunology
Stomach Neoplasms - pathology
Survival analysis
Transforming growth factor-b1
Tryptophan 2,3-dioxygenase
Tumor-infiltrating lymphocytes
title Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A57%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lauren%20classification%20identifies%20distinct%20prognostic%20value%20and%20functional%20status%20of%20intratumoral%20CD8+%20T%20cells%20in%20gastric%20cancer&rft.jtitle=Cancer%20Immunology,%20Immunotherapy&rft.au=Li,%20Ruochen&rft.date=2020-07-01&rft.volume=69&rft.issue=7&rft.spage=1327&rft.epage=1336&rft.pages=1327-1336&rft.issn=0340-7004&rft.eissn=1432-0851&rft_id=info:doi/10.1007/s00262-020-02550-7&rft_dat=%3Cproquest_pubme%3E2414567825%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c431t-2a69089e56aad11a3ac3656db6d92984dad78820daba56718b70cf57a9780c013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2414567825&rft_id=info:pmid/32200421&rfr_iscdi=true